Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Instruments and Supplies

Categories: @artificial-intelligence   

Intuitive Surgical, Inc. design, manufactures, and markets surgical systems. The Company offers endoscopes, endoscopic retractors and disectors, scissors, scalpels, forceps, needle holders, electrocautery, ultrasonic cutters, and accessories during surgical procedures. Intuitive Surgical operates worldwide.
Website: intuitive.com



Growth: Good revenue growth rate 11.5%, there is slowdown compared to average historical growth rates 18.7%. The revenue growth dynamics is moderately stable Site traffic for the last 3 months showed a change of -11.5%

Profitability: LTM EBITDA margin is positive, +29.6%. On average the margin is improving unsteadily. Gross margin is high, +65.9%. In the last quarter the company beat the estimated EPS, +2.5%. The company was ahead of estimated EPS in 60% of quarters (showing a gain of +$0.02 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 0.5% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 110.6% higher than minimum and 3.8% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.8x by EV / Sales multiple , the company can be 78.8% overvalued

Insiders: For the last 3 months insiders sold company shares on $47.1 mln (-0.034% of cap.)

Key Financials (Download financials)

Ticker: ISRG
Share price, USD:  (+1.3%)385.45
year average price 333.31  


year start price 305.27 2023-05-12

min close price 258.49 2023-10-30

max close price 400.59 2024-03-04

current price 385.45 2024-05-10
Common stocks: 358 956 995

Dividend Yield:  0.0%
FCF Yield LTM: 0.5%
EV / LTM EBITDA: 60.4x
EV / EBITDA annualized: 61.2x
Last revenue growth (y/y):  11.5%
Last growth of EBITDA (y/y):  18.1%
Historical revenue growth:  18.7%
Historical growth of EBITDA:  23.1%
EV / Sales: 17.9x
Margin (EBITDA LTM / Revenue): 29.6%
Fundamental value created in LTM:
Market Cap ($m): 138 360
Net Debt ($m): -7 324
EV (Enterprise Value): 131 036
Price to Book: 9.9x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-05-05InvestorPlace

3 Robotics Stocks That Could Be Multibaggers in the Making: Spring Edition

2024-05-02Zacks Investment Research

Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock

2024-04-24Forbes

Should You Pick Intuitive Surgical Stock At $370?

2024-04-22Zacks Investment Research

Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know

2024-04-22MarketBeat

Intuitive Surgical Leads the Robotic Surgery Movement

2024-04-19MarketBeat

Intuitive Surgical Stock Can Trend Much Higher This Year

2024-04-19Zacks Investment Research

Intuitive Surgical (ISRG) Q1 Earnings Beat, Procedures Robust

2024-04-18Investopedia

Intuitive Surgical Stock Jumps After Q1 Earnings Beat Amid da Vinci Robotic System Growth

2024-04-18Seeking Alpha

Intuitive Surgical, Inc. (ISRG) Q1 2024 Earnings Call Transcript

2024-04-18Zacks Investment Research

Intuitive Surgical (ISRG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol ISRG ISRG ISRG ISRG ISRG ISRG ISRG
reportedCurrency USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M
fillingDate 2024-04-19 2024-01-31 2023-10-20 2023-07-24 2023-04-20 2023-02-10 2022-10-21
acceptedDate 2024-04-19 09:00:40 2024-01-31 17:16:45 2023-10-20 17:04:46 2023-07-21 19:22:59 2023-04-20 16:45:19 2023-02-10 17:11:19 2022-10-21 17:03:02
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4 Q3
revenue 1 891M 1 928M 1 744M 1 756M 1 696M 1 655M 1 557M
costOfRevenue 645M 651M 577M 584M 583M 544M 505M
grossProfit 1 245M 1 277M 1 167M 1 172M 1 113M 1 111M 1 052M
grossProfitRatio 0.659 0.662 0.669 0.667 0.656 0.671 0.676
researchAndDevelopmentExpenses 285M 260M 249M 244M 245M 244M 217M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 492M 567M 452M 464M 481M 494M 436M
otherExpenses 0 0 0 0 0 0 0
operatingExpenses 776M 827M 701M 709M 725M 738M 653M
costAndExpenses 1 421M 1 478M 1 278M 1 293M 1 309M 1 283M 1 159M
interestIncome 0 93M 46M 36M 0 22M 4M
interestExpense 0 29M 0 0 -29M 22M 4M
depreciationAndAmortization 109M 123M 109M 97M 93M 106M 90M
ebitda 579M 573M 574M 463M 388M 373M 496M
ebitdaratio 0.306 0.297 0.329 0.264 0.229 0.225 0.318
operatingIncome 469M 450M 466M 366M 295M 266M 399M
operatingIncomeRatio 0.248 0.233 0.267 0.208 0.174 0.161 0.256
totalOtherIncomeExpensesNet 69M 66M 56M 133M 127M 128M 4M
incomeBeforeTax 539M 516M 522M 499M 422M 395M 403M
incomeBeforeTaxRatio 0.285 0.268 0.299 0.284 0.249 0.238 0.259
incomeTaxExpense -9M -95M 102M 73M 61M 58M 78M
netIncome 545M 606M 416M 421M 355M 325M 324M
netIncomeRatio 0.288 0.314 0.238 0.240 0.209 0.196 0.208
eps 1.540 1.720 1.180 1.200 1.010 0.930 0.910
epsdiluted 1.510 1.690 1.160 1.180 1.000 0.910 0.900
weightedAverageShsOut 354M 352M 352M 351M 350M 351M 355M
weightedAverageShsOutDil 361M 358M 358M 357M 356M 357M 361M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol ISRG ISRG ISRG ISRG ISRG ISRG ISRG
reportedCurrency USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M
fillingDate 2024-04-19 2024-01-31 2023-10-20 2023-07-24 2023-04-20 2023-02-10 2022-10-21
acceptedDate 2024-04-19 09:00:40 2024-01-31 17:16:45 2023-10-20 17:04:46 2023-07-21 19:22:59 2023-04-20 16:45:19 2023-02-10 17:11:19 2022-10-21 17:03:02
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 2 840M 2 750M 3 602M 3 435M 371M 1 581M 1 538M
shortTermInvestments 1 961M 2 473M 2 874M 2 364M 2 549M 2 541M 2 781M
cashAndShortTermInvestments 4 800M 5 223M 6 476M 7 132M 6 579M 6 742M 4 319M
netReceivables 1 260M 1 268M 1 097M 904M 925M 942M 971M
inventory 1 299M 1 221M 1 148M 1 005M 947M 893M 837M
otherCurrentAssets 273M 177M 183M 323M 313M 164M 166M
totalCurrentAssets 7 633M 7 888M 8 903M 9 041M 8 451M 8 577M 6 293M
propertyPlantEquipmentNet 3 800M 3 538M 3 077M 2 831M 2 580M 2 374M 2 244M
goodwill 348M 349M 348M 349M 349M 349M 348M
intangibleAssets 34M 637M 638M 693M 5M 50M 57M
goodwillAndIntangibleAssets 382M 985M 987M 349M 349M 349M 405M
longTermInvestments 2 732M 2 120M 1 045M 1 333M 1 886M 2 624M 3 078M
taxAssets 918M 911M 701M 667M 645M 665M 587M
otherNonCurrentAssets 364M 0 0 -316M -857M -1 614M 653M
totalNonCurrentAssets 8 195M 7 554M 5 810M 4 862M 4 603M 4 397M 6 968M
otherAssets 1.000 0 0 0 0 0 0
totalAssets 15 828M 15 442M 14 713M 13 903M 13 053M 12 974M 13 261M
accountPayables 194M 189M 196M 200M 17M 147M 164M
shortTermDebt -438M 25M 0 -200M 0 0 0
taxPayables 52M 111M 343M 230M 125M 96M 71M
deferredRevenue 438M 446M 395M 451M 463M 438M 359M
otherCurrentLiabilities 1 181M 999M 1 085M 1 493M 1 280M 1 276M 639M
totalCurrentLiabilities 1 375M 1 659M 1 676M 1 944M 1 759M 1 861M 1 233M
longTermDebt 0 -82M 0 0 0 0 0
deferredRevenueNonCurrent 50M 46M 43M 45M 45M 41M 37M
deferredTaxLiabilitiesNonCurrent 0 82M 0 0 0 0 0
otherNonCurrentLiabilities 356M 340M 370M 360M 418M 398M 417M
totalNonCurrentLiabilities 407M 386M 413M 405M 463M 439M 453M
otherLiabilities 0 0 0 -405M -463M -439M 0
capitalLeaseObligations 0 65M 0 0 0 0 0
totalLiabilities 1 782M 2 044M 2 089M 1 944M 1 759M 1 861M 1 687M
preferredStock 0 0 0 81M 0 0 0
commonStock 400 000 400 000 400 000 400 000 400 000 400 000 400 000
retainedEarnings 5 068M 4 743M 4 209M 3 808M 3 397M 3 500M 4 018M
accumulatedOtherComprehensiveIncomeLoss -9M -12M -57M -80M -109M -163M -188M
othertotalStockholdersEquity 8 903M 8 576M 8 386M 8 151M 8 005M 7 775M 7 685M
totalStockholdersEquity 13 963M 13 308M 12 539M 11 960M 11 294M 11 113M 11 515M
totalEquity 14 046M 13 397M 12 624M 12 040M 11 294M 11 113M 11 515M
totalLiabilitiesAndStockholdersEquity 15 828M 15 442M 14 713M 13 903M 13 053M 12 974M 13 202M
minorityInterest 84M 90M 85M 81M 77M 71M 0
totalLiabilitiesAndTotalEquity 15 828M 15 442M 14 713M 13 903M 13 053M 12 974M 13 202M
totalInvestments 4 693M 4 593M 3 919M 3 696M 4 436M 5 165M 5 859M
totalDebt 0 90M 0 0 0 0 0
netDebt -2 840M -2 660M -3 602M -3 435M -371M -1 581M -1 538M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link

Cash Flow Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol ISRG ISRG ISRG ISRG ISRG ISRG ISRG
reportedCurrency USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M
fillingDate 2024-04-19 2024-01-31 2023-10-20 2023-07-24 2023-04-20 2023-02-10 2022-10-21
acceptedDate 2024-04-19 09:00:40 2024-01-31 17:16:45 2023-10-20 17:04:46 2023-07-21 19:22:59 2023-04-20 16:45:19 2023-02-10 17:11:19 2022-10-21 17:03:02
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4 Q3
netIncome 545M 611M 420M 426M 361M 337M 325M
depreciationAndAmortization 109M 123M 109M 97M 93M 106M 90M
deferredIncomeTax -7M -220M -43M -27M 9M -83M -62M
stockBasedCompensation 153M 150M 156M 147M 140M 128M 138M
changeInWorkingCapital -540M -439M -101M 6M -244M -61M -124M
accountsReceivables 2M -167M -59M 22M 17M -92M -11M
inventory -180M -184M -240M -162M -127M -128M -174M
accountsPayables -8M 14M -9M 20M 17M -5M 14M
otherWorkingCapital -355M -102M 207M 125M -150M 164M 47M
otherNonCashItems 335M 3M 8M 17M 12M 12M 17M
netCashProvidedByOperatingActivities 39M 228M 548M 666M 371M 438M 383M
investmentsInPropertyPlantAndEquipment -242M -436M -256M -178M -194M -138M -169M
acquisitionsNet -113M -2M 200 000 -7M 0 -1M 200 000
purchasesOfInvestments -906M -1 387M -806M -11M -4M -6M -17M
salesMaturitiesOfInvestments 1 019M 780M 616M 754M 771M 720M 731M
otherInvestingActivites 113M -607M 0 0 0 0 0
netCashUsedForInvestingActivites -129M -1 044M -447M 558M 573M 575M 545M
debtRepayment 0 0 0 0 0 0 0
commonStockIssued 180M 44M 77M 0 100M 234M 0
commonStockRepurchased -227M -66M -15M 0 -350M -1 001M -1 000M
dividendsPaid 0 0 0 0 0 0 0
otherFinancingActivites -500 000 -9M -800 000 63M -131M -197M 73M
netCashUsedProvidedByFinancingActivities 180M -32M 62M 63M -381M -964M -927M
effectOfForexChangesOnCash 7M -5M 2M 5M 2M -3M 2M
netChangeInCash 89M -853M 165M 1 292M 565M 47M 3M
cashAtEndOfPeriod 2 840M 2 770M 3 623M 3 458M 2 166M 1 601M 1 554M
cashAtBeginningOfPeriod 2 750M 3 623M 3 458M 2 166M 1 601M 1 554M 1 551M
operatingCashFlow 39M 228M 548M 666M 371M 438M 383M
capitalExpenditure -242M -436M -256M -178M -194M -138M -169M
freeCashFlow -203M -207M 292M 487M 177M 300M 214M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link

Earning call transcript

2024 q1
2024-04-18 ET (fiscal 2024 q1)
2023 q4
2024-01-23 ET (fiscal 2023 q4)
2023 q3
2023-10-19 ET (fiscal 2023 q3)
2023 q2
2023-07-20 ET (fiscal 2023 q2)
2023 q1
2023-04-18 ET (fiscal 2023 q1)
2022 q4
2023-01-24 ET (fiscal 2022 q4)
2022 q3
2022-10-18 ET (fiscal 2022 q3)
2022 q2
2022-07-21 ET (fiscal 2022 q2)
2022 q1
2022-04-21 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-04-18 20:05 ET
Intuitive Announces First Quarter Earnings
2024-03-14 20:30 ET
Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5
2024-01-23 21:05 ET
Intuitive Announces Fourth Quarter Earnings
2024-01-09 21:05 ET
Intuitive Announces Preliminary Fourth Quarter and Full Year 2023 Results
2023-10-31 20:15 ET
Intuitive Appoints Sreelakshmi Kolli to its Board of Directors
2023-10-19 20:05 ET
Intuitive Announces Third Quarter Earnings
2023-07-20 20:05 ET
Intuitive Announces Second Quarter Earnings
2023-05-16 12:00 ET
Intuitive Announces Executive Leadership Changes
2023-04-28 12:00 ET
Intuitive receives FDA clearance of da Vinci SP for simple prostatectomy
2023-04-18 20:05 ET
Intuitive Announces First Quarter Earnings
2023-01-24 21:05 ET
Intuitive Announces Fourth Quarter Earnings
2023-01-11 14:05 ET
Intuitive Announces Preliminary Fourth Quarter and Full Year 2022 Results
2022-10-19 20:15 ET
Intuitive becomes largest robotic-assisted surgery provider to be accredited by the Royal College of Surgeons of England
2022-10-18 20:05 ET
Intuitive Announces Third Quarter Earnings
2022-09-30 12:30 ET
Japan regulatory agency clears Intuitive’s single-port robotic surgical system
2022-09-27 07:01 ET
Optellum, AI Lung Cancer Diagnosis Innovator, Secures $14M Series A Funding to Accelerate Expansion
2022-07-21 20:05 ET
Intuitive Announces Second Quarter Earnings
2022-06-30 13:15 ET
Intuitive and Siemens Healthineers enhance scanning integration for Ion Endoluminal procedures
2022-04-21 20:05 ET
Intuitive Announces First Quarter Earnings
2022-01-20 21:05 ET
Intuitive Announces Fourth Quarter Earnings
2022-01-12 14:00 ET
Intuitive Announces Preliminary Fourth Quarter and Full Year 2021 Results
2021-12-15 13:45 ET
Intuitive receives FDA clearance for 8 mm SureForm 30 Curved-Tip Stapler
2021-12-14 13:45 ET
Intuitive reaches 10 million procedures performed using da Vinci Surgical Systems
2021-12-14 13:45 ET
Intuitive reaches 10 million procedures performed using da Vinci Surgical Systems
2021-10-19 18:45 ET
Intuitive Announces Executive Leadership Changes
2021-10-19 18:45 ET
Intuitive Announces Third Quarter Earnings
2021-10-18 13:05 ET
PRECIsE Clinical Study Preliminary Results Favorable for Intuitive’s Ion Endoluminal System for Peripheral Nodule Lung Biopsy
2021-08-31 20:25 ET
Intuitive Appoints New General Manager in South Korea
2021-08-05 13:00 ET
Intuitive Board of Directors Approves a Three-For-One Stock Split
2021-07-20 20:05 ET
Intuitive Announces Second Quarter Earnings
2021-04-26 12:45 ET
Intuitive Appoints Dr. Monica P. Reed to its Board of Directors
2021-04-20 20:05 ET
Intuitive Announces First Quarter Earnings
2021-01-21 21:05 ET
Intuitive Announces Fourth Quarter Earnings
2021-01-13 14:05 ET
Intuitive Announces Preliminary Fourth Quarter and Full Year 2020 Results
2020-10-27 12:00 ET
Intuitive Launches $100 Million Venture Capital Fund
2020-10-27 12:00 ET
Intuitive Launches $100 Million Venture Capital Fund
2020-10-15 20:05 ET
Intuitive Announces Third Quarter Earnings
2020-07-21 20:05 ET
Intuitive Announces Second Quarter Earnings
2020-04-28 20:15 ET
Intuitive Provides Update on Supporting Customers, Communities & Employees during COVID-19
2020-04-27 20:15 ET
Intuitive Appoints Joseph C. Beery to its Board of Directors
2020-04-16 20:05 ET
Intuitive Announces First Quarter Earnings
2020-04-08 13:15 ET
Intuitive Announces Preliminary First Quarter Results; Provides Update on COVID-19 Impact
2020-02-10 21:01 ET
Intuitive Acquires Orpheus Medical to Expand Informatics Platform for Hospitals
2020-02-03 21:01 ET
Intuitive Announces Retirement of Board Chair Lonnie M. Smith; Dr. Craig H. Barratt Succeeds Smith as New Chair
2020-01-23 21:05 ET
Intuitive Announces Fourth Quarter Earnings
2020-01-09 21:05 ET
Intuitive Announces Preliminary Fourth Quarter and Full Year 2019 results
2019-11-26 23:40 ET
U.S. FDA Clears SynchroSeal and E-100 Generator for da Vinci X/Xi Platforms
2019-10-17 20:05 ET
Intuitive Announces Third Quarter Earnings
2019-04-18 20:05 ET
Intuitive Announces First Quarter Earnings
2019-03-15 17:36 ET
U.S. FDA Clears da Vinci SP for Certain Transoral Otolaryngology Procedures
2019-02-19 16:18 ET
U. S. FDA Grants Clearance for Ion by Intuitive
2019-01-24 21:05 ET
Intuitive Surgical Announces Fourth Quarter Earnings
2019-01-09 14:05 ET
Intuitive Surgical Announces Preliminary Fourth Quarter and Full Year 2018 Results

SEC forms

Show financial reports only

SEC form 10
2024-04-19 09:00 ET
Intuitive Surgical published news for 2024 q1
SEC form 10
2024-04-19 00:00 ET
Intuitive Surgical published news for 2024 q1
SEC form 8
2024-04-18 16:04 ET
Intuitive Surgical published news for 2024 q1
SEC form 8
2024-04-18 16:04 ET
Intuitive Surgical reported for 2024 q1
SEC form 10
2024-01-31 00:00 ET
Intuitive Surgical published news for 2023 q4
SEC form 8
2024-01-23 16:02 ET
Intuitive Surgical reported for 2023 q4
SEC form 8
2024-01-23 16:02 ET
Intuitive Surgical published news for 2023 q4
SEC form 8
2024-01-09 00:00 ET
Intuitive Surgical published news for 2023 q4
SEC form 8
2024-01-09 00:00 ET
Intuitive Surgical published news for 2023 q4
SEC form 8
2024-01-09 00:00 ET
Intuitive Surgical reported for 2023 q4
SEC form 10
2023-10-20 17:04 ET
Intuitive Surgical published news for 2023 q3
SEC form 10
2023-10-20 00:00 ET
Intuitive Surgical published news for 2023 q3
SEC form 8
2023-10-19 16:04 ET
Intuitive Surgical reported for 2023 q3
SEC form 10
2023-07-24 00:00 ET
Intuitive Surgical published news for 2023 q2
SEC form 6
2023-07-20 16:00 ET
Intuitive Surgical reported for 2023 q2
SEC form 10
2023-04-20 00:00 ET
Intuitive Surgical published news for 2023 q1
SEC form 8
2023-04-18 00:00 ET
Intuitive Surgical reported for 2023 q1
SEC form 10
2023-02-10 17:11 ET
Intuitive Surgical reported for 2022 q4
SEC form 10
2023-02-10 00:00 ET
Intuitive Surgical reported for 2022 q4
SEC form 6
2023-02-02 16:51 ET
Intuitive Surgical published news for 2022 q4
SEC form 6
2023-01-24 16:01 ET
Intuitive Surgical published news for 2022 q4
SEC form 8
2023-01-24 00:00 ET
Intuitive Surgical reported for 2022 q4
SEC form 6
2023-01-11 09:01 ET
Intuitive Surgical published news for 2022 q4
SEC form 8
2023-01-11 00:00 ET
Intuitive Surgical reported for 2022 q4
SEC form 6
2022-10-25 09:00 ET
Intuitive Surgical published news for 2022 q3
SEC form 10
2022-10-21 17:03 ET
Intuitive Surgical reported for 2022 q3
SEC form 10
2022-10-21 00:00 ET
Intuitive Surgical reported for 2022 q3
SEC form 6
2022-10-18 16:06 ET
Intuitive Surgical published news for 2022 q3
SEC form 8
2022-10-18 00:00 ET
Intuitive Surgical reported for 2022 q3
SEC form 6
2022-10-04 18:09 ET
Intuitive Surgical published news for 2022 q3
SEC form 6
2022-08-02 09:00 ET
Intuitive Surgical published news for 2022 q2
SEC form 10
2022-07-22 17:24 ET
Intuitive Surgical reported for 2022 q2
SEC form 10
2022-07-22 00:00 ET
Intuitive Surgical reported for 2022 q2
SEC form 6
2022-07-21 16:05 ET
Intuitive Surgical published news for 2022 q2
SEC form 8
2022-07-21 00:00 ET
Intuitive Surgical reported for 2022 q2
SEC form 6
2022-05-02 18:45 ET
Intuitive Surgical published news for 2022 q1
SEC form 10
2022-04-22 17:26 ET
Intuitive Surgical reported for 2022 q1
SEC form 10
2022-04-22 00:00 ET
Intuitive Surgical reported for 2022 q1
SEC form 6
2022-04-21 16:08 ET
Intuitive Surgical published news for 2022 q1
SEC form 8
2022-04-21 00:00 ET
Intuitive Surgical reported for 2022 q1
SEC form 6
2022-03-09 17:25 ET
Intuitive Surgical published news for 2021 q4
SEC form 10
2022-02-03 16:59 ET
Intuitive Surgical published news for 2021 q4
SEC form 10
2022-02-03 00:00 ET
Intuitive Surgical published news for 2021 q4
SEC form 6
2022-01-20 16:05 ET
Intuitive Surgical published news for 2021 q4
SEC form 8
2022-01-20 00:00 ET
Intuitive Surgical published news for 2021 q4
SEC form 6
2022-01-12 09:00 ET
Intuitive Surgical published news for 2021 q4
SEC form 8
2022-01-12 00:00 ET
Intuitive Surgical published news for 2021 q4
SEC form 6
2022-01-10 16:28 ET
Intuitive Surgical published news for 2021 q4
SEC form 6
2022-01-07 17:49 ET
Intuitive Surgical published news for 2021 q4
SEC form 10
2021-10-20 17:01 ET
Intuitive Surgical published news for 2021 q3
SEC form 10
2021-10-20 00:00 ET
Intuitive Surgical published news for 2021 q3
SEC form 6
2021-10-19 14:51 ET
Intuitive Surgical published news for 2021 q3
SEC form 8
2021-10-19 00:00 ET
Intuitive Surgical published news for 2021 q3
SEC form 6
2021-09-23 17:01 ET
Intuitive Surgical published news for 2021 q2
SEC form 6
2021-08-18 19:58 ET
Intuitive Surgical published news for 2021 q2
SEC form 6
2021-08-05 09:05 ET
Intuitive Surgical published news for 2021 q2
SEC form 6
2021-08-05 08:50 ET
Intuitive Surgical published news for 2021 q2
SEC form 10
2021-07-21 17:14 ET
Intuitive Surgical published news for 2021 q2
SEC form 10
2021-07-21 00:00 ET
Intuitive Surgical published news for 2021 q2
SEC form 6
2021-07-20 16:01 ET
Intuitive Surgical published news for 2021 q2
SEC form 8
2021-07-20 00:00 ET
Intuitive Surgical published news for 2021 q2
SEC form 6
2021-04-26 16:01 ET
Intuitive Surgical published news for 2021 q1
SEC form 6
2021-04-23 12:54 ET
Intuitive Surgical published news for 2021 q1
SEC form 10
2021-04-21 16:25 ET
Intuitive Surgical published news for 2021 q1
SEC form 10
2021-04-21 00:00 ET
Intuitive Surgical published news for 2021 q1
SEC form 6
2021-04-20 16:01 ET
Intuitive Surgical published news for 2021 q1
SEC form 8
2021-04-20 00:00 ET
Intuitive Surgical published news for 2021 q1
SEC form 6
2021-03-10 16:37 ET
Intuitive Surgical published news for 2020 q4
SEC form 10
2021-02-09 21:47 ET
Intuitive Surgical published news for 2020 q4
SEC form 6
2021-02-01 17:00 ET
Intuitive Surgical published news for 2020 q4
SEC form 6
2021-01-21 16:01 ET
Intuitive Surgical published news for 2020 q4
SEC form 6
2021-01-13 09:00 ET
Intuitive Surgical published news for 2020 q4
SEC form 10
2020-10-19 17:22 ET
Intuitive Surgical published news for 2020 q3
SEC form 6
2020-10-15 16:00 ET
Intuitive Surgical published news for 2020 q3